HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antagonistic activity of etizolam on platelet-activating factor in vivo experiments.

Abstract
The ability of etizolam, 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), an anti-anxiety drug, to inhibit platelet-activating factor (PAF)-induced reactions was investigated in experimental animals in vivo. Etizolam (0.01-0.3 mg/kg, i.v.) dose dependently inhibited PAF (0.3 microgram/kg, i.v.)-induced bronchoconstriction (Konzett and Rössler's method) in guinea pigs, but even at doses as large as 3 mg/kg, i.v., it had no effect on bronchoconstriction induced by histamine, serotonin, acetylcholine, arachidonic acid, bradykinin, angiotensin l or leukotriene D4. Etizolam (0.1-1 mg/kg, i.v.) also dose-dependently reversed PAF (1 microgram/kg, i.v.)-induced hypotension in anesthetized rats. Injection of PAF into the tail veins of mice produced lethal shock within 10-30 min. Etizolam (0.1-3 mg/kg, i.v. and 1-10 mg/kg, p.o.) protected against the lethal effect of PAF (75 micrograms/kg, i.v.) in a dose-dependent manner. These results indicate that etizolam specifically inhibits the action of PAF in vivo.
AuthorsM Terasawa, H Mikashima, T Tahara, Y Maruyama
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 44 Issue 4 Pg. 381-6 (Aug 1987) ISSN: 0021-5198 [Print] Japan
PMID3682404 (Publication Type: Journal Article)
Chemical References
  • Bronchodilator Agents
  • Platelet Activating Factor
  • Tranquilizing Agents
  • etizolam
  • Diazepam
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Bronchi (drug effects)
  • Bronchodilator Agents
  • Diazepam (analogs & derivatives, pharmacology)
  • Female
  • Guinea Pigs
  • Lethal Dose 50
  • Male
  • Mice
  • Mice, Inbred ICR
  • Platelet Activating Factor (antagonists & inhibitors)
  • Rats
  • Species Specificity
  • Tranquilizing Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: